Return to homepagePandemic Pact

Retrospective cohort study to evaluate the effect of NSAIDs and ACE inhibitors on the prognosis of symptomatic patients with COVID-19.

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00527

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    Raquel Cobos Campos

  • Research Location

    Spain

  • Lead Research Institution

    ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOARABA

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

To determine if patients with confirmed SARS-CoV-2 infection, treated with drugs that increase the expression of angiotensin converting enzyme 2 8 IECAS, ARB and / or NSAIDs) have a higher risk of poor disease progression (pneumonia, acute respiratory syndrome and cardiac involvement), mortality or hospital admission than patients not treated with these drugs. A retrospective study of all patients with confirmed SARS-CoV-2 virus infection in Alava is proposed. All patients with confirmed infection will be followed up from the first contact with the health system until its resolution (negative test) or death, if applicable. The data will precede the electronic medical history of each patient.